HS

Hans-Wilhelm Schwaeble

UL University Of Leicester: 19 patents #1 of 136Top 1%
OM Omeros: 15 patents #5 of 108Top 5%
📍 Mountsorrel, GB: #1 of 6 inventorsTop 20%
Overall (All Time): #231,971 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
12005117 Methods for inhibiting fibrosis in a subject in need thereof Nigel John Brunskill, Gregory A. Demopulos, Thomas Dudler 2024-06-11
11981748 Methods for inhibiting angiogenesis in a subject in need thereof Gregory A. Demopulos, Thomas Dudler, Larry W. Tjoelker 2024-05-14
11981749 Methods for treating conditions associated with MASP-2 dependent complement activation Gregory A. Demopulos, Thomas Dudler 2024-05-14
11896621 Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant Gregory A. Demopulos, Thomas Dudler 2024-02-13
11884742 Methods for treating conditions associated with MASP-2 dependent complement activation Clark E. Tedford, James Brian Parent, Thomas Dudler, Gregory A. Demopulos 2024-01-30
11525011 Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome Gregory A. Demopulos, Thomas Dudler 2022-12-13
11013772 Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant Gregory A. Demopulos, Thomas Dudler 2021-05-25
10870708 Methods for inhibiting angiogenesis in a subject in need thereof Gregory A. Demopulos, Thomas Dudler, Larry W. Tjoelker 2020-12-22
10736960 Methods for inhibiting fibrosis in a subject in need thereof Nigel John Brunskill, Gregory A. Demopulos, Tom Dudler 2020-08-11
10660317 Genetically modified non-human mammals and cells Teizo Fujita, Cordula Margaret Stover 2020-05-26
10626184 Monoclonal antibodies, compositions and methods for detecting mucin-like protein (MLP) as a biomarker for ovarian and pancreatic cancer Gregory A. Demopulos 2020-04-21
10202465 Methods for treating conditions associated with MASP-2 dependent complement activation Gregory A. Demopulos, Thomas Dudler 2019-02-12
10059776 Methods for treating conditions associated with MASP-2 dependent complement activation Gregory A. Demopulos, Thomas Dudler 2018-08-28
9644035 Methods for treating conditions associated with MASP-2 dependent complement activation Gregory A. Demopulos, Thomas Dudler 2017-05-09
8951522 Methods for treating conditions associated with MASP-2 dependent complement activation Gregory A. Demopulos, Thomas Dudler 2015-02-10
8840893 Methods for treating conditions associated with MASP-2 dependent complement activation Clark E. Tedford, James Brian Parent, Thomas Dudler, Gregory A. Demopulos 2014-09-23
8785717 Genetically modified non-human mammals and cells Teizo Fujita, Cordula Margaret Stover 2014-07-22
8652477 Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation Thomas Dudler, Clark E. Tedford, James Brian Parent, Gregory A. Demopulos 2014-02-18
7919094 Methods for treating conditions associated with MASP-2 dependent complement activation Cordula Margaret Stover, Clark E. Tedford, James Brian Parent, Teizo Fujita 2011-04-05